Geoff Brooke
Founder at ACTINOGEN MEDICAL LIMITED
Net worth: 78 686 $ as of 2024-03-30
Profile
Geoff Edward Duncan Brooke is the founder of GBS Venture Partners Pty Ltd.
(founded in 1996) and MedVest, Inc. (founded in 1996).
He is currently the Independent Non-Executive Chairman at Actinogen Medical Ltd.
(founded in 1999).
Dr. Brooke's current job(s) include being the Independent Non-Executive Chairman at Cynata Therapeutics Ltd.
(since 2019), Director at OcuNexus Therapeutics, Inc., Non-Executive Director at ChemGenex Pharmaceuticals, Inc., Independent Non-Executive Director at Acrux Ltd.
(since 2016), Director at Cerylid Biosciences Ltd., Director at CoDa Therapeutics (NZ) Ltd., and Independent Non-Executive Director at Prevatex Pty Ltd.
Dr. Brooke's former job(s) include being a Director at Cogstate Ltd., Non-Executive Director at Nuwellis, Inc. (from 2002 to 2011), Director at Uptake Medical Corp., Director at Antipodean Pharmaceuticals, Inc., Independent Non-Executive Director at ChemGenex Pharmaceuticals Pty Ltd.
(from 2007 to 2011), Independent Director at Victorian WorkCover Authority (from 2009 to 2015), Director at Promix Pty Ltd., Director at Phenomix Australia Pty Ltd., and Non-Executive Director at Health.com.au Pty Ltd.
Dr. Brooke's education history includes an undergraduate degree from the University of Melbourne and an MBA from the International Institute for Management Development.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-29 | 2,240,699 ( 0.10% ) | 46 786 $ | 2024-03-30 | |
2023-06-29 | 257,343 ( 0.14% ) | 31 900 $ | 2024-03-30 |
Geoff Brooke active positions
Companies | Position | Start |
---|---|---|
ACRUX LIMITED | Director/Board Member | 2016-05-31 |
ACTINOGEN MEDICAL LIMITED | Founder | 1999-03-22 |
CYNATA THERAPEUTICS LIMITED | Chairman | 2020-08-17 |
ChemGenex Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA. | Director/Board Member | 2011-06-02 |
Cerylid Biosciences Ltd.
Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia. | Director/Board Member | 2011-03-16 |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Director/Board Member | 2010-03-24 |
CoDa Therapeutics (NZ) Ltd.
CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Director/Board Member | - |
Prevatex Pty Ltd.
Prevatex Pty Ltd. BiotechnologyHealth Technology Prevatex Pty Ltd. is an Australian company that focuses on restoring optimal gut health. The company is based in Geelong West, Australia. The company address the issue of the loss of important gut microbes due to changes in our modern lifestyle, such as bleaching of fresh foods, antibiotic use, and stress. The company was founded by James A. Campbell and Gregory Collier. | Director/Board Member | - |
Former positions of Geoff Brooke
Companies | Position | End |
---|---|---|
Victorian WorkCover Authority | Director/Board Member | 2014-12-31 |
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Geoff Brooke
University of Melbourne | Undergraduate Degree |
International Institute for Management Development | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
COGSTATE LIMITED | Commercial Services |
NUWELLIS, INC. | Health Technology |
ACRUX LIMITED | Health Technology |
ACTINOGEN MEDICAL LIMITED | Health Technology |
CYNATA THERAPEUTICS LIMITED | Health Technology |
Private companies | 14 |
---|---|
Uptake Medical Corp.
Uptake Medical Corp. Medical SpecialtiesHealth Technology Uptake Medical Corp. develops medical technologies for the treatment of lung diseases. It provides InterVapor, an endoscopic lung volume reduction solution for people with severe emphysema that uses the body’s natural healing process without leaving implants or foreign materials in the lung; and InterVapor Personalized Procedure Program, a proprietary application that recommends treatment locations and ablation energy durations for each patient based on the patient’s CT scan. The company was founded by Robert L. Barry in 2004 and is headquartered in Tustin, CA. | Health Technology |
Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Health Technology |
ChemGenex Pharmaceuticals Pty Ltd.
ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia. | Health Technology |
Victorian WorkCover Authority | Government |
ChemGenex Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA. | Health Technology |
Cerylid Biosciences Ltd.
Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia. | Health Technology |
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Finance |
Promix Pty Ltd.
Promix Pty Ltd. Pharmaceuticals: MajorHealth Technology Promix Pty Ltd. develops pharmaceuticals and researches medical diagnostic products. The company was founded in 1999 and is headquartered in Narangba, Australia. | Health Technology |
MedVest, Inc. | |
CoDa Therapeutics (NZ) Ltd.
CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Health Technology |
Phenomix Australia Pty Ltd. | |
Health.com.au Pty Ltd.
Health.com.au Pty Ltd. Life/Health InsuranceFinance Health.com.au Pty Ltd. operates as an online health insurance firm. It provides health insurance products and services and other health benefits to its members. The firm's policies cover clients for same day and overnight stays, meals, nurses, operating theatre costs, intensive care, and government-approved surgically implanted prostheses. Its plans also cover services including dental, physiotherapy, optical, chiropractic, and podiatry. The company was founded by Andy Sheats in June 2011 and is headquartered in Abbortsford, Australia. | Finance |
Prevatex Pty Ltd.
Prevatex Pty Ltd. BiotechnologyHealth Technology Prevatex Pty Ltd. is an Australian company that focuses on restoring optimal gut health. The company is based in Geelong West, Australia. The company address the issue of the loss of important gut microbes due to changes in our modern lifestyle, such as bleaching of fresh foods, antibiotic use, and stress. The company was founded by James A. Campbell and Gregory Collier. | Health Technology |
- Stock Market
- Insiders
- Geoff Brooke